Patents by Inventor Andrew George Hardeman

Andrew George Hardeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL QUETIAPINE SUSPENSION FORMULATIONS WITH EXTENDED SHELF LIFE AND ENHANCED BIOAVAILABILITY
    Publication number: 20240342189
    Abstract: A quetiapine fumarate composition for oral administration is provided comprising a pharmaceutically acceptable salt or solvate of quetiapine existing as a suspension in an aqueous carrier agent. The inventive liquid formulation demonstrates high bioavailability consistent with approved dosage forms, low agglomeration, reduced content of excipients commonly used in solid oral dosage forms and extended shelf life stability. Also provided is a method of manufacturing a liquid quetiapine suspension composition for oral administration and methods of administering therapeutically effective dosages of an oral liquid quetiapine suspension composition to patients in need thereof.
    Type: Application
    Filed: June 25, 2024
    Publication date: October 17, 2024
    Inventors: Carl David Tierney, Andrew John Gardner, Jan Paul Pick-Katolik, Stacey Elaine Powell, Mark Foley, Laurence Charles Ramsey, Andrew George Hardeman
  • Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability
    Patent number: 12023340
    Abstract: A quetiapine fumarate composition for oral administration is provided comprising a pharmaceutically acceptable salt or solvate of quetiapine existing as a suspension in an aqueous carrier agent. The inventive liquid formulation demonstrates high bioavailability consistent with approved dosage forms, low agglomeration, reduced content of excipients commonly used in solid oral dosage forms and extended shelf life stability. Also provided is a method of manufacturing a liquid quetiapine suspension composition for oral administration and methods of administering therapeutically effective dosages of an oral liquid quetiapine suspension composition to patients in need thereof.
    Type: Grant
    Filed: February 24, 2021
    Date of Patent: July 2, 2024
    Inventors: Carl David Tierney, Andrew John Gardner, Jan Paul Pick-Katolik, Stacey Elaine Powell, Mark Foley, Laurence Charles Ramsey, Andrew George Hardeman
  • ORAL QUETIAPINE SUSPENSION FORMULATIONS WITH EXTENDED SHELF LIFE AND ENHANCED BIOAVAILABILITY
    Publication number: 20210260073
    Abstract: A quetiapine fumarate composition for oral administration is provided comprising a pharmaceutically acceptable salt or solvate of quetiapine existing as a suspension in an aqueous carrier agent. The inventive liquid formulation demonstrates high bioavailability consistent with approved dosage forms, low agglomeration, reduced content of excipients commonly used in solid oral dosage forms and extended shelf life stability. Also provided is a method of manufacturing a liquid quetiapine suspension composition for oral administration and methods of administering therapeutically effective dosages of an oral liquid quetiapine suspension composition to patients in need thereof.
    Type: Application
    Filed: February 24, 2021
    Publication date: August 26, 2021
    Inventors: Carl David Tierney, Andrew John Gardner, Jan Paul Pick-Katolik, Stacey Elaine Powell, Mark Foley, Laurence Charles Ramsey, Andrew George Hardeman